SS
LENZ

Steve Schonfeld’s LENZ Therapeutics LENZ Stock Holding History

Steve Schonfeld’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
53,462
+14,177
+36% +$114K ﹤0.01% 2029
2026
Q1 		$359K Buy
+39,285
New +$552K ﹤0.01% 1507
2024
Q4 		– Sell
-107,300
Closed -$2.55M – 2466
2024
Q3 		$2.55M Buy
+107,300
New +$2.38M 0.02% 784
2022
Q4 		– Sell
-3,371
Closed -$75K – 3073
2022
Q3 		$75K Sell
3,371
-2,986
-47% -$71.2K ﹤0.01% 2598
2022
Q2 		$122K Buy
+6,357
New +$142K ﹤0.01% 2079

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Steve Schonfeld's LENZ Position: Q2 2026 in Review

Steve Schonfeld increased its LENZ Therapeutics (LENZ) stake by 36% in Q2 2026, buying an estimated $114K and bringing the position to 53,462 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #2029.

Steve Schonfeld first reported a position in LENZ in Q2 2022 and has held it in 5 quarters since. The position peaked at $2.55M in Q3 2024. 143 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Steve Schonfeld held 53,462 shares of LENZ Therapeutics worth $304K as of Q2 2026.
  • Steve Schonfeld bought 14,177 LENZ Therapeutics shares in Q2 2026, an estimated $114K.
  • LENZ Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2029 holding.
  • Steve Schonfeld first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 5 quarters since.
  • Steve Schonfeld's LENZ Therapeutics position peaked at $2.55M in Q3 2024.
  • 143 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.